Delivery Order SPE2DB22D2007-SPE2DB24FJ4RU

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML pharmaceuticals. The order, valued at $8,224.66, has a completion date of November 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not designated as a set-aside. The company holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The award, valued at $2,769.68, is for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.8ML, a pharmaceutical product. The contract has an ultimate completion date of June 4, 2024 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,038.07, is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.6ML, a pharmaceutical product. The contract has a completion date of July 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The $5,441.80 contract has a performance period ending on June 13, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the company to supply a wide range of pharmaceutical products and medical supplies...
This is a $7,131.67 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, and has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565805238 MOUNJARO 15 MG/0.5 ML PEN 0.5ML. The contract is a firm-fixed-price delivery order with a ceiling value of $1,578.00 and an ultimate completion date of September 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,632.54, is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a medication. The award has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,360.45 firm fixed-price contract is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medication. The contract has an ultimate completion date of April 10, 2025 and is not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,632.54, is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,176.72 contract is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a prescription medication. The award has an ultimate completion date of April 23, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ4RU
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The $1,995.76 firm fixed price contract has a completion date of July 31, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC serves as a primary vehicle for AmerisourceBergen to provide a wide range of medical commodities, including prescription drugs and supplies, to support military treatment programs and facilities worldwide. The contract was not set aside for any specific socioeconomic category of businesses.

Generated 10/29/24, 9:10 AM